Renan Ozyerli of MSD Turkey provides insights into the transformation of Turkey’s healthcare ecosystem over the past decade, highlighting how MSD works hand-in-hand with the government to broaden access to life-changing innovation. He also pinpoints MSD’s exceptional and enduring commitment to Turkey, which has led the company to emerge as one of the largest investors in clinical trials in the country.
Leveraging your 25 years of experience in the pharmaceutical and healthcare sector, what would you highlight as the most remarkable specificities of the Turkish model of healthcare?
"The Turkish healthcare system now stands as an efficient model adopting new advances in digital technologies such as e-prescriptions and newly launched e-diagnosis."
